20-34710110-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021202.3(TP53INP2):āc.466C>Gā(p.Leu156Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000126 in 1,266,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021202.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TP53INP2 | NM_021202.3 | c.466C>G | p.Leu156Val | missense_variant | 5/5 | ENST00000374810.8 | |
TP53INP2 | NM_001329429.2 | c.466C>G | p.Leu156Val | missense_variant | 5/5 | ||
TP53INP2 | NM_001329430.2 | c.466C>G | p.Leu156Val | missense_variant | 4/4 | ||
TP53INP2 | NM_001329431.2 | c.466C>G | p.Leu156Val | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TP53INP2 | ENST00000374810.8 | c.466C>G | p.Leu156Val | missense_variant | 5/5 | 1 | NM_021202.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151736Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000108 AC: 12AN: 1114242Hom.: 0 Cov.: 33 AF XY: 0.0000112 AC XY: 6AN XY: 535584
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151844Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74210
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.466C>G (p.L156V) alteration is located in exon 5 (coding exon 3) of the TP53INP2 gene. This alteration results from a C to G substitution at nucleotide position 466, causing the leucine (L) at amino acid position 156 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at